These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

332 related articles for article (PubMed ID: 34454807)

  • 21. A longitudinal cohort study of watch and wait in complete clinical responders after chemo-radiotherapy for localised rectal cancer: study protocol.
    Vatandoust S; Wattchow D; Sposato L; Michael MZ; Leung J; Gormly K; Chen G; Symonds EL; Tie J; Papanicolas LE; Woods S; Gebski V; Mead K; Kuruni A; Karapetis CS
    BMC Cancer; 2022 Mar; 22(1):222. PubMed ID: 35232427
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Oncological Outcomes and Hospital Costs of the Treatment in Patients With Rectal Cancer: Watch-and-Wait Policy and Standard Surgical Treatment.
    Hupkens BJP; Breukink SO; Stoot JHMB; Toebes RE; van der Sande ME; Melenhorst J; Beets GL; Dirksen CD
    Dis Colon Rectum; 2020 May; 63(5):598-605. PubMed ID: 32032202
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Salvage surgery for local regrowths in Watch & Wait - Are we harming our patients by deferring the surgery?
    Nasir I; Fernandez L; Vieira P; Parés O; Santiago I; Castillo-Martin M; Domingos H; Cunha JF; Carvalho C; Heald RJ; Beets GL; Parvaiz A; Figueiredo N
    Eur J Surg Oncol; 2019 Sep; 45(9):1559-1566. PubMed ID: 31006589
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Long-term outcomes of clinical complete responders after neoadjuvant treatment for rectal cancer in the International Watch & Wait Database (IWWD): an international multicentre registry study.
    van der Valk MJM; Hilling DE; Bastiaannet E; Meershoek-Klein Kranenbarg E; Beets GL; Figueiredo NL; Habr-Gama A; Perez RO; Renehan AG; van de Velde CJH;
    Lancet; 2018 Jun; 391(10139):2537-2545. PubMed ID: 29976470
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Long-term Quality of Life and Functional Outcome of Patients With Rectal Cancer Following a Watch-and-Wait Approach.
    Custers PA; van der Sande ME; Grotenhuis BA; Peters FP; van Kuijk SMJ; Beets GL; Breukink SO;
    JAMA Surg; 2023 May; 158(5):e230146. PubMed ID: 36988922
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Great Debates: Surgery or Watch and Wait After Total Neoadjuvant Therapy for Rectal Cancer.
    Ali A; Lee WF; O'Leary MP; Whealon M
    Am Surg; 2024 Oct; 90(10):2362-2366. PubMed ID: 38655585
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Intentional Watch and Wait or Organ Preservation Surgery Following Neoadjuvant Chemoradiotherapy Plus Consolidation CAPEOX for MRI-defined Low-risk Rectal Cancer: Findings From a Prospective Phase 2 Trial (PKUCH-R01 Trial, NCT02860234).
    Wang L; Zhang XY; Zhao YM; Li SJ; Li ZW; Sun YS; Wang WH; Wu AW;
    Ann Surg; 2023 Apr; 277(4):647-654. PubMed ID: 35766394
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Selected stage IV rectal cancer patients managed by the watch-and-wait approach after pelvic radiotherapy: a good alternative to total mesorectal excision surgery?
    Custers PA; Hupkens BJP; Grotenhuis BA; Kuhlmann KFD; Breukink SO; Beets GL; Melenhorst J;
    Colorectal Dis; 2022 Apr; 24(4):401-410. PubMed ID: 35060263
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Long-term outcome of patients with rectal cancer who achieve complete or near complete clinical responses after neoadjuvant therapy: a multicenter registry study of data from the Chinese Watch and Wait Database].
    Zhao YM; Wang WH; Zhang W; Wang L; Li S; Wang JW; Liao LE; Yu GY; Sun Z; Qu YL; Gong Y; Lu Y; Wu T; Li YF; Wang Q; Zhao GH; Xiao Y; Ding PR; Zhang Z; Wu AW
    Zhonghua Wei Chang Wai Ke Za Zhi; 2024 Apr; 27(4):372-382. PubMed ID: 38644243
    [No Abstract]   [Full Text] [Related]  

  • 30. Comparing outcomes and cost in surgery versus watch & wait surveillance of patients with rectal cancer post neoadjuvant long course chemoradiotherapy.
    Crean R; Glyn T; McCombie A; Frizelle F
    ANZ J Surg; 2024 Jun; 94(6):1151-1160. PubMed ID: 38486505
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Diagnosis and treatment strategy for clinical complete responders after chemoradiotherapy for rectal cancer: is watch-and-wait policy safe?].
    Yao HW; Liu YH
    Zhonghua Wai Ke Za Zhi; 2017 Jul; 55(7):496-499. PubMed ID: 28655076
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Early results from implementation of a 'watch and wait' protocol for complete clinical response following chemoradiotherapy for rectal cancer.
    Balasuriya HD; Timon C; Entriken F; Neely D; Herron J; Tang C; Van Hazel G; Warner MW
    ANZ J Surg; 2022 Nov; 92(11):2961-2967. PubMed ID: 35841184
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Factors affecting local regrowth after watch and wait for patients with a clinical complete response following chemoradiotherapy in rectal cancer (InterCoRe consortium): an individual participant data meta-analysis.
    Chadi SA; Malcomson L; Ensor J; Riley RD; Vaccaro CA; Rossi GL; Daniels IR; Smart NJ; Osborne ME; Beets GL; Maas M; Bitterman DS; Du K; Gollins S; Sun Myint A; Smith FM; Saunders MP; Scott N; O'Dwyer ST; de Castro Araujo RO; Valadao M; Lopes A; Hsiao CW; Lai CL; Smith RK; Paulson EC; Appelt A; Jakobsen A; Wexner SD; Habr-Gama A; Sao Julião G; Perez R; Renehan AG
    Lancet Gastroenterol Hepatol; 2018 Dec; 3(12):825-836. PubMed ID: 30318451
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Principle of surgical management for rectal cancer patients with complete clinical response after neoadjuvant therapy].
    Li XX; Luo DK
    Zhonghua Wei Chang Wai Ke Za Zhi; 2019 Apr; 22(4):342-348. PubMed ID: 31054548
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cost analysis of a watch-and-wait approach in patients with a complete clinical response to chemoradiotherapy for rectal cancer.
    Cooper EA; Hodder RJ; Finlayson A; Filgate R; Coveney A; Balasuriya HD; Warner MW
    ANZ J Surg; 2022 Nov; 92(11):2956-2960. PubMed ID: 35855528
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Quality of Life in Rectal Cancer Patients After Chemoradiation: Watch-and-Wait Policy Versus Standard Resection - A Matched-Controlled Study.
    Hupkens BJP; Martens MH; Stoot JH; Berbee M; Melenhorst J; Beets-Tan RG; Beets GL; Breukink SO
    Dis Colon Rectum; 2017 Oct; 60(10):1032-1040. PubMed ID: 28891846
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Avoiding Radical Surgery in Elderly Patients With Rectal Cancer Is Cost-Effective.
    Rao C; Sun Myint A; Athanasiou T; Faiz O; Martin AP; Collins B; Smith FM
    Dis Colon Rectum; 2017 Jan; 60(1):30-42. PubMed ID: 27926555
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Analysis on efficacy and safety of total neoadjuvant therapy in patients with locally advanced rectal cancer with high risk factors].
    Ouyang GL; Meng WJ; Shu P; Deng XB; Wu B; Jiang D; Zhuang H; Shen YL; Zhou ZG; Wang ZQ; Wang X
    Zhonghua Wei Chang Wai Ke Za Zhi; 2019 Apr; 22(4):349-356. PubMed ID: 31054549
    [No Abstract]   [Full Text] [Related]  

  • 39. Light and shadow of watch-and-wait strategy in rectal cancer: oncological result, clinical outcomes, and cost-effectiveness analysis.
    Ferri V; Vicente E; Quijano Y; Duran H; Diaz E; Fabra I; Malave L; Ruiz P; Costantini G; Pizzuti G; Cubillo A; Rubio MC; Cañamaque LG; Alfonsel JN; Caruso R
    Int J Colorectal Dis; 2023 Dec; 38(1):277. PubMed ID: 38051359
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A Dynamic Clinical Calculator for Estimating Conditional Recurrence-Free Survival After Total Neoadjuvant Therapy for Rectal Cancer and Either Surgery or Watch-and-Wait Management.
    Weiser MR; Chou JF; Kim JK; Widmar M; Wei IH; Pappou EP; Smith JJ; Nash GM; Paty PB; Cercek A; Saltz LB; Romesser PB; Crane CH; Garcia-Aguilar J; Schrag D; Gönen M
    JAMA Netw Open; 2022 Sep; 5(9):e2233859. PubMed ID: 36173634
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.